Project: Every Child for Younger Patients With Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Desmoid Type-fibromatosis
- Carcinoma in Situ
- Central Nervous System Neoplasm
- Childhood Immature Teratoma
- Childhood Langerhans Cell Histiocytosis
- Childhood Mature Teratoma
- Congenital Mesoblastic Nephroma
- Lymphoproliferative Disorder
- Malignant Solid Neoplasm
- Myeloproliferative Neoplasm
- Stromal Neoplasm
- Type
- Observational
- Design
- Observational Model: CohortTime Perspective: Prospective
Participation Requirements
- Age
- Younger than 25 years
- Gender
- Both males and females
Description
PRIMARY OBJECTIVES: I. To maintain a Childhood Cancer Registry for infants, children, adolescents, and young adults with cancer. II. To utilize clinical and biological data to help determine eligibility or stratification, based on childhood cancer disease classification schemas, for potential enroll...
PRIMARY OBJECTIVES: I. To maintain a Childhood Cancer Registry for infants, children, adolescents, and young adults with cancer. II. To utilize clinical and biological data to help determine eligibility or stratification, based on childhood cancer disease classification schemas, for potential enrollment of research subjects onto Children's Oncology Group (COG) therapeutic clinical trials. III. To develop a well annotated childhood cancer biorespository for current and future research through the collection of biospecimens (at diagnosis, time of progression, time of recurrence and/or post-mortem), including tumor, host and when feasible parental germline deoxyribonucleic acid (DNA); and key clinical data, including presentation, diagnostic, staging, summary treatment, and outcome information, from every child diagnosed with cancer at COG institutions. IV. To allow use of registry data for permission to be contacted in the future to consider participating in non-therapeutic and prevention research studies involving the child or their parents. OUTLINE: Patients undergo medical data review to create a Childhood Cancer Registry. Patients also undergo collection of biospecimen samples (e.g., tissue, blood, bone marrow, plasma, serum, saliva, cerebrospinal fluid, or urine).
Tracking Information
- NCT #
- NCT02402244
- Collaborators
- National Cancer Institute (NCI)
- Investigators
- Principal Investigator: Douglas Hawkins Children's Oncology Group